Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-200
Closed -$1K 348
2022
Q2
$1K Hold
200
﹤0.01% 281
2022
Q1
$1K Hold
200
﹤0.01% 441
2021
Q4
$1K Hold
200
﹤0.01% 333
2021
Q3
$2K Hold
200
﹤0.01% 283
2021
Q2
$1K Hold
200
﹤0.01% 302
2021
Q1
$1K Hold
200
﹤0.01% 272
2020
Q4
$1K Buy
+200
New +$1.27K ﹤0.01% 312

Other funds holding VXRT

Providence Capital Advisors's VXRT Position: Q3 2022 in Review

Providence Capital Advisors sold out of Vaxart (VXRT) in Q3 2022, closing a stake of 200 shares — an estimated $1K sold.

Providence Capital Advisors first reported a position in VXRT in Q4 2020 and held it in 7 quarters. The position peaked at $2K in Q3 2021. 143 funds tracked by Wall St. Rank hold VXRT as of Q3 2022.

  • Providence Capital Advisors reported no remaining Vaxart position as of Q3 2022 after selling out during the quarter.
  • Providence Capital Advisors sold 200 Vaxart shares in Q3 2022, an estimated $1K.
  • Providence Capital Advisors first reported a position in Vaxart in Q4 2020 and held it in 7 quarters.
  • Providence Capital Advisors's Vaxart position peaked at $2K in Q3 2021.
  • 143 funds tracked by Wall St. Rank held Vaxart as of Q3 2022.

Based on Providence Capital Advisors's 13F filing for Q3 2022, filed 9 Nov 2022.